FDA Approves New Drug For Pain That Persists After Shingles
The US Food and Drug Administration (FDA) announced yesterday that it has approved Qutenza (capsaicin) 8% patch for the treatment of post-herpetic neuralgia (PHN), an often excruciating pain that can persist for weeks, months and even years in 10 to 15 per cent of people who get shingles. The medicated skin patch, which is made by Lohmann Therapie-Systems AD of Andernach, Germany and distributed in the US by NeurogesX Inc.
Posted by SkinDoc on Wednesday, November 18, 2009, at 4:02 pm. Filed under Skin Care News. Tagged Andernach Germany, Excruciating Pain, Fda, Fda Approved, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Neurogesx Inc, People, Post Herpetic Neuralgia, Shingles, Skin Patch, Therapie, Us Food And Drug Administration.
Both comments and trackbacks are currently closed.
